Benefits
Restorative sleep improvement
The clinical trial showed a 64% greater improvement in restorative sleep quality in the Serezin group vs. placebo at 4 weeks. Unlike melatonin or sedatives, Serezin works by reducing pain that disrupts sleep rather than directly inducing sedation.
Nighttime and daytime pain reduction
By Day 7, significant improvements in pain scores were observed. By Day 28, subjects experienced a 2.6x greater reduction in nighttime discomfort and a 75% greater reduction in daytime discomfort vs. placebo — addressing a root cause of poor sleep in aging adults.
Sleep onset and quality
By Day 14, subjects showed 85% greater improvement in ease of falling asleep and 93% greater improvements in sleep quality vs. placebo (Leeds Sleep Evaluation Questionnaire). Benefits were consistent across both male and female participants, including a women-only analysis presented at sleep 2025.
Mood and morning alertness
Serezin subjects reported a 2.2x improvement in overall mood scores and significantly easier time waking, with greater morning alertness — addressing the full sleep experience rather than just sleep onset.
Mechanism of action
Boswellic acid anti-inflammatory activity
Boswellia serrata extract inhibits 5-lipoxygenase (5-LOX), the enzyme that produces pro-inflammatory leukotrienes responsible for joint and soft tissue inflammation. This targeted anti-inflammatory action reduces the chronic low-grade pain that disrupts sleep quality in aging adults.
Ginger COX inhibition and analgesic activity
Zingiber officinale constituents (gingerols, shogaols) inhibit cyclooxygenase (COX-1 and COX-2) enzymes, reducing prostaglandin-mediated pain signaling. The synergistic combination of 5-LOX inhibition (Boswellia) and COX inhibition (ginger) provides broader pain pathway coverage than either alone.
Circadian rhythm preservation
By addressing pain as the root cause of sleep disruption rather than forcing sedation, Serezin preserves natural sleep architecture and circadian rhythm integrity — allowing deeper, more restorative sleep stages to occur naturally.
Clinical trials
4-week randomized, double-blind, placebo-controlled study in 60 healthy adults aged 50-70 with disturbed sleep due to evening pain. (Manufacturer-published; PLT Health Solutions)
50 recreationally active men (mean age 28 ± 4) randomized to 60 mg standardized B. serrata extract LI51202F1 (the same extract used in Serezin™, water-soluble, ≥76% AKBA) or placebo for 10 days (6 days before, day of, and 3 days after downhill running). DOMS induced by three 15-min downhill running episodes on a 10% declined treadmill. Conducted by PLT Health Solutions and Yalamanchi Hospital and Research Centre.
B. serrata significantly attenuated muscle and joint soreness (VAS) and accelerated recovery of leg-extension 1RM strength after eccentric exercise vs placebo. The full Serezin® product (Boswellia + ginger) was also tested in a separate 4-week, 60-person 50-70 yr trial in adults with sleep disturbance from aches/pains; the abstract appeared in sleep 2025 Supplement (doi 10.1093/sleep/zsaf090.0941, conference abstract — not individually PubMed-indexed). PLT-reported Serezin findings: 64% greater restorative sleep improvement at 4 weeks, 2.6× reduction in nighttime discomfort, 75% reduction in daytime discomfort, 2.2× mood improvement. The full Serezin paper has not yet been published in PubMed-indexed peer-reviewed form. supports the Boswellia component's mechanism and DOMS/recovery effect.